106 related articles for article (PubMed ID: 8142118)
1. Serum soluble interleukin-2 receptor in colorectal cancer.
Murakami S; Satomi A; Ishida K; Murai H; Okamura Y
Acta Oncol; 1994; 33(1):19-21. PubMed ID: 8142118
[TBL] [Abstract][Full Text] [Related]
2. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer.
Sakata H; Murakami S; Hirayama R
Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066
[TBL] [Abstract][Full Text] [Related]
4. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
[TBL] [Abstract][Full Text] [Related]
5. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
Ito H; Miki C
Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
[TBL] [Abstract][Full Text] [Related]
6. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer.
Murakami S; Sakata H; Tsuji Y; Okubo K; Hamada S; Hirayama R
Dig Surg; 2002; 19(1):9-13; discussion 14. PubMed ID: 11961349
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
9. Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study.
Miki C; Inoue Y; Hiro J; Ojima E; Araki T; Uchida K; Kusunoki M
Dis Colon Rectum; 2006 Nov; 49(11):1710-8. PubMed ID: 16990975
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients.
Kawashima O; Kamiyoshihara M; Sakata S; Endo K; Saito R; Morishita Y
Ann Surg Oncol; 2000 Apr; 7(3):239-45. PubMed ID: 10791856
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
[TBL] [Abstract][Full Text] [Related]
12. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of cyclooxygenase-2 in the prediction of liver metastasis of colorectal carcinoma].
Lu XY; Xu JM; Zhong YS; Ren L; Lai YH; Qin XY
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):54-7. PubMed ID: 17403293
[TBL] [Abstract][Full Text] [Related]
14. The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients.
Pakdel A; Malekzadeh M; Naghibalhossaini F
Cancer Biomark; 2016; 16(2):245-52. PubMed ID: 26756614
[TBL] [Abstract][Full Text] [Related]
15. Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?
Li Destri G; Lanteri R; Santangelo M; Torrisi B; Di Cataldo A; Puleo S
World J Surg; 2006 Aug; 30(8):1494-9. PubMed ID: 16847713
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma.
Pavlidis N; Nicolaides C; Bairaktari E; Kalef-Ezra J; Athanassiadis A; Seferiadis C; Fountzilas G
Int J Biol Markers; 1996; 11(1):6-11. PubMed ID: 8740635
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
18. Use of the preoperative levels of CEA in patients with colorectal cancer.
Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
[TBL] [Abstract][Full Text] [Related]
19. [Rule of lymph node metastasis in colorectal cancer and its affecting factors].
Tu SL; Ye ZY; Deng GL; Zhao ZS; Dong QJ; Zheng BA; Ding LP; Cao HF
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):257-60. PubMed ID: 17520386
[TBL] [Abstract][Full Text] [Related]
20. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
